MLIC
BMY.RT

Mandatum Life Insurance Company’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Mandatum Life Insurance Company’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-57,600
Closed -$26K – 114
2020
Q4 		$26K Hold
57,600
– – 0.01% 107
2020
Q3 		$85K Buy
+57,600
New +$164K 0.02% 101

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Mandatum Life Insurance Company's BMY.RT Position: Q1 2021 in Review

Mandatum Life Insurance Company sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 57,600 shares — an estimated $26K sold.

Mandatum Life Insurance Company first reported a position in BMY.RT in Q3 2020 and held it in 2 quarters. The position peaked at $85K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Mandatum Life Insurance Company reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Mandatum Life Insurance Company sold 57,600 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $26K.
  • Mandatum Life Insurance Company first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q3 2020 and held it in 2 quarters.
  • Mandatum Life Insurance Company's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $85K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Mandatum Life Insurance Company's 13F filing for Q1 2021, filed 11 May 2021.